Dermata Therapeutics: Q2 Earnings Insights

Comments
Loading...

 

Dermata Therapeutics DRMA reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Dermata Therapeutics beat estimated earnings by 25.0%, reporting an EPS of $-0.24 versus an estimate of $-0.32.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 7.26% drop in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Dermata Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

DRMA Logo
DRMADermata Therapeutics Inc
$1.22-0.81%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum7.32
Growth-
Quality-
Value-
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: